public health expertsupdatedpneumococcal vaccination recommendations for adults 19 and older. The updated guidelines recommend that adults who have only had the pneumococcal polysaccharide vaccine (PPSV) get a polysaccharide conjugate vaccine (PCV). ...
The recommended first age at which Americans should get thepneumococcal vaccinehas been lowered from 65 to 50, the U.S. Centers for Disease Control andPreventionannounced Wednesday. "Lowering the age forpneumococcal vaccinationgives more adults the opportunity to protect themselves from pneumococcal dise...
- 《Pediatric Infectious Disease Journal》 被引量: 532发表: 2012年 Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis In March 2010, 13-valent pneumococcal conjugate vaccine (PCV13) replaced the seven-...
February 25, 2010(UPDATED March 3, 2010)— The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) voted on February 24 to recommend the use of a 13-valent pneumococcal conjugate vaccine (PCV13), which provides broader protection for young children...
Invasive pneumococcal disease and 13-valent pneumococcal conjugate vaccine (PCV13) coverage among children aged ≤59 months---selected U.S. regions, 2010--... On March 12, 2010, the Advisory Committee on Immunization Practices (ACIP) published recommendations for use of a newly licensed, 13-val...
Adverse Reactions to Pneumococcal Vaccine in Pediatric and Adolescent Patients with Sickle Cell Disease Study Objective To review five cases of severe adverse reactions after vaccination with the 23-valent pneumococcal polysaccharide vaccine (PPSV23) in pedia... J Han,O Kemiki,LL Hsu,... - 《Pha...
A new CDC advisory lowers the recommended age that Americans receive a pneumococcal vaccine to help prevent pneumonia and other dangerous illnesses. Previously, Americans over the age of 65 were recommended to get the shot; now, the age has been lowered to 50 and older. Besides older adults, ...